Drug that Inhibits DNA-repair Enzyme Shrinks Some Breast and Ovarian Tumors

NCI Cancer Bulletin • July 13, 2010

In two small phase II clinical trials, the drug olaparib, which blocks a DNA-repair enzyme called PARP, shrank tumors or stopped the progression of advanced breast and ovarian cancer in some women with inherited BRCA1 or BRCA2 gene mutations.

Potential Benefit of Screening Women at Average Risk for Ovarian Cancer

WebMD Health News • May 20, 2010

A new screening approach shows promise for the detection of ovarian cancer in postmenopausal women at average risk of the disease, early testing suggests.

Wanda Jankelson Foundation for Health Care and Research Makes $500,000 Challenge Gift to the Marsha Rivkin Center

Press Release • March 3, 2010

In a landmark contribution to the Marsha Rivkin Center for Ovarian Cancer Research, the Wanda Jankelson Foundation for Health Care and Research has made a $500,000 "challenge" gift to help advance innovative research in ovarian cancer.

Newly published results from Dr. Nicole Urban and colleagues

Ovarian Cancer Study Tests Lead Time of Potential Biomarkers

NCI Cancer Bulletin • January 12, 2010

Teams of scientists around the world are working to develop ways to detect early signs of ovarian cancer in blood. Considerable progress has been made in understanding the disease ...

Nicole Urban, Ph.D.: Making Progress in Cancer Detection

Seattle Woman Magazine • October, 2009

“I wanted to do something where I could make a difference,” says Nicole Urban, Ph.D. And making a difference is exactly what Urban has been doing for the past 25 years as a leading researcher at the Fred Hutchinson Cancer Research Center in Seattle.

Modified Chemo Regimen Effective in Advanced Ovarian Cancer

NCI Cancer Bulletin • September 22, 2009

Women with advanced ovarian cancer lived longer and without their tumors growing after receiving a modified regimen of a standard chemotherapy drug combination, Japanese researchers reported...

Risk of Ovarian Cancer from Hormone Therapy Confirmed

NCI Cancer Bulletin • July 14, 2009

Women who have taken hormone therapy are at a higher risk of developing ovarian cancer than women who have not, according to a nationwide study involving nearly 910,000 women in Denmark.

Genetic Clue to Rare Ovarian Cancers Found

NCI Cancer Bulletin • June 16, 2009

Canadian researchers have identified a gene mutation that appears to be common in a rare form of ovarian cancer known as granulosa-cell tumors.

Protein a clue to ovary cancer

NCI Cancer Bulletin • September 5, 2008

In Washington state -- where more women die from ovarian cancer than in most parts of the country -- tumors are too often diagnosed too late...

MRC Funded Research: Symptoms Found for Early Check On Ovary Cancer

NY Times • June 13, 2007

Cancer experts have identified a set of health problems that may be symptoms of ovarian cancer, and they are urging women who have the symptoms for more than a few weeks to see their doctors.

Roccer Moms Raise $10,000

Seattle Times • May 10, 2007

Tami Vogeler and Teri Chambers call themselves the Roccer Moms. That's not a spelling error...